JPWO2021231243A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021231243A5
JPWO2021231243A5 JP2022568549A JP2022568549A JPWO2021231243A5 JP WO2021231243 A5 JPWO2021231243 A5 JP WO2021231243A5 JP 2022568549 A JP2022568549 A JP 2022568549A JP 2022568549 A JP2022568549 A JP 2022568549A JP WO2021231243 A5 JPWO2021231243 A5 JP WO2021231243A5
Authority
JP
Japan
Prior art keywords
alkyl
independently
diseases
pharma
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022568549A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023525527A (ja
JP7677995B2 (ja
JP2023525527A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/031479 external-priority patent/WO2021231243A1/en
Publication of JP2023525527A publication Critical patent/JP2023525527A/ja
Publication of JPWO2021231243A5 publication Critical patent/JPWO2021231243A5/ja
Publication of JP2023525527A5 publication Critical patent/JP2023525527A5/ja
Application granted granted Critical
Publication of JP7677995B2 publication Critical patent/JP7677995B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022568549A 2020-05-11 2021-05-10 ガレクチン-3の低分子阻害剤 Active JP7677995B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063022627P 2020-05-11 2020-05-11
US63/022,627 2020-05-11
PCT/US2021/031479 WO2021231243A1 (en) 2020-05-11 2021-05-10 Small molecule inhibitors of galectin-3

Publications (4)

Publication Number Publication Date
JP2023525527A JP2023525527A (ja) 2023-06-16
JPWO2021231243A5 true JPWO2021231243A5 (https=) 2024-05-20
JP2023525527A5 JP2023525527A5 (https=) 2024-05-20
JP7677995B2 JP7677995B2 (ja) 2025-05-15

Family

ID=76284161

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022568549A Active JP7677995B2 (ja) 2020-05-11 2021-05-10 ガレクチン-3の低分子阻害剤

Country Status (6)

Country Link
US (1) US12286424B2 (https=)
EP (1) EP4149939A1 (https=)
JP (1) JP7677995B2 (https=)
KR (1) KR20230009433A (https=)
CN (1) CN115551850A (https=)
WO (1) WO2021231243A1 (https=)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401301D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel 3-triazolyl-galactoside inhibitors of galectins
SE0401300D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel Galactoside Inhibitors of Galectins
US8828971B2 (en) 2012-10-10 2014-09-09 Galectin Therapeutics, Inc. Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders
JP2015535233A (ja) 2012-10-31 2015-12-10 ガレクト・バイオテック・エイビイ ガレクチン−3のガラクトシド阻害剤及び肺線維症のためのその使用
JP6904906B2 (ja) 2015-01-30 2021-07-21 ガレクト・バイオテック・エイビイ ガレクチンの新規なガラクトシド阻害剤
ES2921500T3 (es) 2015-11-09 2022-08-26 Galecto Biotech Ab 1,1'-sulfanodiil-di-beta-d-galactopiranósidos como inhibidores de galectinas
CA3062648A1 (en) 2017-05-12 2018-11-15 Galectin Sciences, Llc Compounds for the prevention and treatment of diseases and the use thereof
US20200061095A1 (en) * 2017-05-12 2020-02-27 Galectin Sciences, Llc Compounds for the Treatment of Systemic Insulin Resistance Disorders and the Use Thereof
EP3953349A1 (en) * 2019-04-10 2022-02-16 Bristol-Myers Squibb Company Small molecule inhibitors of galectin-3

Similar Documents

Publication Publication Date Title
JP2021169499A5 (https=)
JP7656669B2 (ja) マトリックスメタロプロテイナーゼ(mmp)阻害剤及びその使用方法
JP2005531609A5 (https=)
JP2016517432A5 (https=)
JP2019034943A5 (https=)
JP7577682B2 (ja) ガレクチン-3の低分子阻害剤
JP2020510664A5 (https=)
JP2021527102A5 (https=)
JP2021502387A5 (https=)
JP2015164972A5 (https=)
JP2010540555A5 (https=)
JPWO2019126086A5 (https=)
JPWO2020210308A5 (https=)
JPWO2019126085A5 (https=)
JP2021530488A5 (https=)
RU2017145086A (ru) Производные 3-(6-хлор-3-оксо-3,4-дигидро-(2h)-1,4-бензоксазин-4-ил)пропионовой кислоты и их применение в качестве ингибиторов kmo
JPWO2021231243A5 (https=)
JPWO2020198266A5 (https=)
JPWO2021076688A5 (https=)
JPWO2021226002A5 (https=)
JP2006506350A5 (https=)
JPWO2019241461A5 (https=)
JPWO2021262812A5 (https=)
JPWO2021242982A5 (https=)
JP2021512894A (ja) 治療用化合物および組成物